[visionrehabtherapist] FW: ALERT!--Drug Label Access Improvements Pass House; On Track for President's Desk!
- From: "McCall, Roberta (LARA)" <mccallr@xxxxxxxxxxxx>
- To: "'visionrehabtherapist@xxxxxxxxxxxxx'" <visionrehabtherapist@xxxxxxxxxxxxx>
- Date: Fri, 22 Jun 2012 11:50:00 -0400
fyi
________________________________
From: AFB DirectConnect [mailto:MRichert@xxxxxxx]
Sent: Thursday, June 21, 2012 10:15 AM
To: AFB Subscriber
Subject: ALERT!--Drug Label Access Improvements Pass House; On Track for
President's Desk!
[http://www.afb.org/learn/icimage.asp?ImageID=1254]
ALERT!--Accessible Drug Label Bill Passed in House!
Measure on Course for President's Signature!
For further information, contact:
Mark Richert, Esq.
Director, Public Policy, AFB
(202) 469-6833
MRichert@xxxxxxx<mailto:mrichert@xxxxxxx>
Yesterday, the U.S. House of Representatives passed comprehensive legislation,
the Food and Drug Administration Safety and Innovation Act. Advocates will
recall that companion legislation had previously passed the Senate including
provisions that would establish national best practices for retail and other
pharmacies to use in providing accessible prescription drug labeling to their
customers with vision loss. Once these best practices are promulgated, a
Government Accountability Office (GAO) study will assess the extent to which
pharmacies are employing such best practices and improving access. Once
enacted, these provisions will serve as a valuable supplement to existing
requirements under the Americans with Disabilities Act and other federal and
state laws imposing obligations on pharmacies to ensure effective communication
and barrier removal for people with disabilities.
While the House bill had not included the drug label provisions in prior
versions, the version of the bill brought to the House floor yesterday did
contain them, along with a variety of other changes reflecting the informal,
behind the scenes, negotiations by House and Senate staff and Members to
reconcile the differences between the House and Senate approaches. This is a
good illustration of how Congress may forgo the formality of conference
committee proceedings in favor of a more streamlined, but arguably less
transparent, legislative process. Such a streamlined process reflects the
overwhelmingly bipartisan commitment in both houses of Congress to act by
September 30 of this year to enact the vast array of complex policy issues
addressed by the legislation.
The President is expected to sign the bill once yesterday's House-passed
version is formally endorsed by the Senate; action in the Senate is anticipated
within the next ten days. Congratulations to all advocates and organizations
who have contributed to this effort and worked so hard to bring much-needed
attention to the significant public health challenge of inaccessible
prescription drug labeling.
You can unsubscribe at any time. To remove your name from this mailing list, or
to find out what other newsletters are available from AFB, visit
http://www.afb.org/myAFBNewsletter2.asp.
Other related posts:
- » [visionrehabtherapist] FW: ALERT!--Drug Label Access Improvements Pass House; On Track for President's Desk! - McCall, Roberta (LARA)
